Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -7.36% is 96% above its 3-year average of -173.18%, near the high end of its 3-year range (-521.11%–-7.36%).
As of the fiscal period ended Tuesday, March 31, 2026. 95.38% above its 12-month average of -159.40%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q3 FY2026 (2026-03-31): -7.36%.
RETURN ON EQUITY (ROE)
-7.36%
RETURN ON EQUITY (ROE) AVG TTM
-159.40%
RETURN ON EQUITY (ROE) AVG 3Y
-173.18%
RETURN ON EQUITY (ROE) AVG 5Y
N/A
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+95.38%
CURRENT VS 3Y AVG
+95.75%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-39.54%
median of 577 covered companies
CURRENT VS SECTOR MEDIAN
+81.39%
vs the sector median at left
Advanced Biomed Inc. Common Stock
Market Cap
$9.25M
Return on Equity (ROE)
-7.36%
TTM Avg
-159.40%
3Y Avg
-173.18%
5Y Avg
N/A
Market Cap
$9.15M
Return on Equity (ROE)
-317.20%
TTM Avg
510.39%
3Y Avg
317.15%
5Y Avg
239.40%
Market Cap
$9.39M
Return on Equity (ROE)
-2248.48%
TTM Avg
-970.82%
3Y Avg
-532.13%
5Y Avg
-347.08%
Market Cap
$9.87M
Return on Equity (ROE)
-440.15%
TTM Avg
-145.56%
3Y Avg
-96.97%
5Y Avg
-42.16%
Market Cap
$9.82M
Return on Equity (ROE)
-211.76%
TTM Avg
-295.58%
3Y Avg
-182.53%
5Y Avg
-207.81%
Market Cap
$10.05M
Return on Equity (ROE)
N/A
TTM Avg
18596.99%
3Y Avg
9182.42%
5Y Avg
7349.85%
Market Cap
$8.53M
Return on Equity (ROE)
-34.67%
TTM Avg
10.89%
3Y Avg
102.13%
5Y Avg
71.00%
Market Cap
$9.92M
Return on Equity (ROE)
-189.76%
TTM Avg
-774.75%
3Y Avg
-460.85%
5Y Avg
-442.56%
Market Cap
$10.09M
Return on Equity (ROE)
-506.63%
TTM Avg
-300.20%
3Y Avg
-300.20%
5Y Avg
-300.20%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Advanced Biomed Inc. Common Stock (ADVB) | $9.25M | -7.36% | -159.40% | -173.18% | N/A |
| SeaStar Medical Holding Corporation (ICU)vs › | $9.15M | -317.20% | 510.39% | 317.15% | 239.40% |
| Jasper Therapeutics, Inc. (JSPR)vs › | $9.39M | -2248.48% | -970.82% | -532.13% | -347.08% |
| Ainos, Inc. (AIMD)vs › | $9.87M | -440.15% | -145.56% | -96.97% | -42.16% |
| MetaVia Inc. (MTVA)vs › | $9.82M | -211.76% | -295.58% | -182.53% | -207.81% |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.05M | N/A | 18596.99% | 9182.42% | 7349.85% |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.53M | -34.67% | 10.89% | 102.13% | 71.00% |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $9.92M | -189.76% | -774.75% | -460.85% | -442.56% |
| Caring Brands, Inc. (CABR)vs › | $10.09M | -506.63% | -300.20% | -300.20% | -300.20% |
| DataMEDS AI, Inc. (MEDS)vs › | $8.30M | N/A | 355.89% | 202.91% | 202.91% |
ROE
-7.4%
ROA
-6.4%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-03-31 | -7.36% |
| 2025-12-31 | -521.11% |
| 2025-06-30 | -48.89% |
| 2025-03-31 | -60.22% |
| 2024-12-31 | -184.98% |
| 2024-09-30 | -115.41% |
| 2024-06-30 | -106.30% |
| 2024-03-31 | -158.68% |
| 2023-09-30 | -370.40% |
| 2023-06-30 | -257.33% |
| 2023-03-31 | -74.24% |
